[New therapeutic possibility in severe gram negative bacillus infections].
D001419:Bacteria / Q000187:drug effects*; D001424:Bacterial Infections / Q000188:drug therapy*; D004341:Drug Evaluation; D004352:Drug Resistance, Microbial; D004361:Drug Tolerance; D006801:Humans; D009268:Nalidixic Acid / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D018805:Sepsis / Q000188:drug therapy
D009268:Nalidixic Acid
Nouvelle possibilité thérapeutique dans les infections sévères à bacilles gram négatif